125 related articles for article (PubMed ID: 14678183)
1. Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients.
Kinjo M; Okegawa T; Horie S; Nutahara K; Higashihara E
Int J Urol; 2004 Jan; 11(1):38-43. PubMed ID: 14678183
[TBL] [Abstract][Full Text] [Related]
2. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating uroplakin-positive cells in patients with transitional cell carcinoma of the bladder.
Li SM; Zhang ZT; Chan S; McLenan O; Dixon C; Taneja S; Lepor H; Sun TT; Wu XR
J Urol; 1999 Sep; 162(3 Pt 1):931-5. PubMed ID: 10458411
[TBL] [Abstract][Full Text] [Related]
4. Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma.
Retz M; Lehmann J; Röder C; Plötz B; Harder J; Eggers J; Pauluschke J; Kalthoff H; Stöckle M
Cancer Res; 1998 Dec; 58(24):5662-6. PubMed ID: 9865718
[TBL] [Abstract][Full Text] [Related]
5. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
6. Detection of occult tumor cells in lymph nodes from bladder cancer patients by MUC7 nested RT-PCR.
Retz M; Lehmann J; Szysnik C; Zwank S; Venzke T; Röder C; Kalthoff H; Basbaum C; Stöckle M
Eur Urol; 2004 Mar; 45(3):314-9. PubMed ID: 15036676
[TBL] [Abstract][Full Text] [Related]
7. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: detection of circulating cancer cells in the peripheral blood of metastatic patients.
Yuasa T; Yoshiki T; Isono T; Tanaka T; Hayashida H; Okada Y
Int J Urol; 1999 Jun; 6(6):286-92. PubMed ID: 10404304
[TBL] [Abstract][Full Text] [Related]
8. Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.
Retz M; Lehmann J; Amann E; Wullich B; Röder C; Stöckle M
J Urol; 2003 Jan; 169(1):86-9. PubMed ID: 12478110
[TBL] [Abstract][Full Text] [Related]
9. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue.
Shen SS; Smith CL; Hsieh JT; Yu J; Kim IY; Jian W; Sonpavde G; Ayala GE; Younes M; Lerner SP
Cancer; 2006 Jun; 106(12):2610-6. PubMed ID: 16700038
[TBL] [Abstract][Full Text] [Related]
11. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction.
Fujii Y; Kageyama Y; Kawakami S; Kihara K; Oshima H
Jpn J Cancer Res; 1999 Jul; 90(7):753-7. PubMed ID: 10470288
[TBL] [Abstract][Full Text] [Related]
12. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
13. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
15. [Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging].
Nagy V; Rosocha J; Zidzik J; Bohus P
Klin Onkol; 2011; 24(4):287-92. PubMed ID: 21905620
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
17. Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; Kajita Y; Matsui Y; Ito M; Nishiyama H; Kerr N; da Silva Tatley F; Cambridge L; Toro T; Ogawa O; Guilford P
Clin Cancer Res; 2008 Feb; 14(3):742-9. PubMed ID: 18245534
[TBL] [Abstract][Full Text] [Related]
18. Bradeion (SEPT4) as a urinary marker of transitional cell bladder cancer: a real-time polymerase chain reaction study of gene expression.
Bongiovanni L; Pirozzi F; Guidi F; Orsini M; Chiurazzi P; Bassi PF; Racioppi M
J Urol; 2012 Jun; 187(6):2223-7. PubMed ID: 22503047
[TBL] [Abstract][Full Text] [Related]
19. Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation.
Xu B; He Y; Wu X; Luo C; Liu A; Zhang J
J Urol; 2012 Oct; 188(4):1346-53. PubMed ID: 22906662
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer.
Saidi S; Popov Z; Janevska V; Panov S
Int Braz J Urol; 2017; 43(2):224-229. PubMed ID: 28128913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
